Ortivus AB today announces that it has completed the sale of its entire shareholding in the technology company H&E Solutions AB (Evam) for a purchase price of SEK 5.2 million. The transaction results in a realised profit and strengthens Ortivus’ liquidity, while the successful collaboration relating to MobiMed enRoute continues unchanged.
In January 2023, Ortivus acquired approximately 10 per cent of the shares in H&E Solutions AB for SEK 4.0 million. Since then, the companies have maintained a close and successful collaboration, particularly in the development and integration of MobiMed enRoute – a navigation and case management solution that forms a module within the Ortivus MobiMed platform.
Ortivus has now chosen to sell its shareholding in H&E Solutions AB for SEK 5.2 million. The decision is based on the fact that H&E Solutions has brought in new, well-capitalised owners, creating a favourable opportunity for Ortivus to realise a profit on its investment and further strengthen the company’s liquidity.
“We are selling our shares in H&E Solutions as a strategic decision that strengthens our cash position and enables us to realise a solid return. It is important to emphasise that our close collaboration regarding MobiMed enRoute will continue as before. This is a highly valuable solution for our customers, and we look forward to continuing to deliver market-leading solutions for pre-hospital care together,” says Gustaf Nordenhök, CEO of Ortivus.
The divestment does not affect the operational collaboration between the companies or the functionality of the products offered to Ortivus’ customers.